Hotline: +86-18022463983    020-85206863

Global Injectable Targeted Therapy Market Research Report 2024

Published Date: 2024-03-29   |   Pages: 80   |   Tables: 170   |  Medical Care

It is at the cellular and molecular level, designed for the treatment of well-defined carcinogenic sites, and designing corresponding therapeutic drugs. When drugs enter the body, they will specifically select carcinogenic sites to combine and act, causing tumor cells to die specifically, without Will affect the normal tissue cells around the tumor.

The global Injectable Targeted Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

North American market for Injectable Targeted Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Injectable Targeted Therapy is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Injectable Targeted Therapy in Hospitals is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Injectable Targeted Therapy include Novartis, Sanofi, GSK, Bayer, Amgen, Merck, AbbiVie, AstraZeneca and Teva, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Injectable Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Injectable Targeted Therapy.

Report Scope

The Injectable Targeted Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Injectable Targeted Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Injectable Targeted Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

Novartis

Sanofi

GSK

Bayer

Amgen

Merck

AbbiVie

AstraZeneca

Teva

Roche

Pfizer

Segment by Type

Monoclonal Antibodies

Small-Molecules

Immunotoxins

Others

Segment by Application

Hospitals

Homecare

Specialty Clinics

Others

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Injectable Targeted Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Injectable Targeted Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Monoclonal Antibodies

1.2.3 Small-Molecules

1.2.4 Immunotoxins

1.2.5 Others

1.3 Market by Application

1.3.1 Global Injectable Targeted Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Homecare

1.3.4 Specialty Clinics

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Injectable Targeted Therapy Market Perspective (2019-2030)

2.2 Injectable Targeted Therapy Growth Trends by Region

2.2.1 Global Injectable Targeted Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Injectable Targeted Therapy Historic Market Size by Region (2019-2024)

2.2.3 Injectable Targeted Therapy Forecasted Market Size by Region (2025-2030)

2.3 Injectable Targeted Therapy Market Dynamics

2.3.1 Injectable Targeted Therapy Industry Trends

2.3.2 Injectable Targeted Therapy Market Drivers

2.3.3 Injectable Targeted Therapy Market Challenges

2.3.4 Injectable Targeted Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Injectable Targeted Therapy Players by Revenue

3.1.1 Global Top Injectable Targeted Therapy Players by Revenue (2019-2024)

3.1.2 Global Injectable Targeted Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Injectable Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Injectable Targeted Therapy Revenue

3.4 Global Injectable Targeted Therapy Market Concentration Ratio

3.4.1 Global Injectable Targeted Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Injectable Targeted Therapy Revenue in 2023

3.5 Injectable Targeted Therapy Key Players Head office and Area Served

3.6 Key Players Injectable Targeted Therapy Product Solution and Service

3.7 Date of Enter into Injectable Targeted Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Injectable Targeted Therapy Breakdown Data by Type

4.1 Global Injectable Targeted Therapy Historic Market Size by Type (2019-2024)

4.2 Global Injectable Targeted Therapy Forecasted Market Size by Type (2025-2030)

5 Injectable Targeted Therapy Breakdown Data by Application

5.1 Global Injectable Targeted Therapy Historic Market Size by Application (2019-2024)

5.2 Global Injectable Targeted Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Injectable Targeted Therapy Market Size (2019-2030)

6.2 North America Injectable Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Injectable Targeted Therapy Market Size by Country (2019-2024)

6.4 North America Injectable Targeted Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Injectable Targeted Therapy Market Size (2019-2030)

7.2 Europe Injectable Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Injectable Targeted Therapy Market Size by Country (2019-2024)

7.4 Europe Injectable Targeted Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Injectable Targeted Therapy Market Size (2019-2030)

8.2 Asia-Pacific Injectable Targeted Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Injectable Targeted Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Injectable Targeted Therapy Market Size (2019-2030)

9.2 Latin America Injectable Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Injectable Targeted Therapy Market Size by Country (2019-2024)

9.4 Latin America Injectable Targeted Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Injectable Targeted Therapy Market Size (2019-2030)

10.2 Middle East & Africa Injectable Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Injectable Targeted Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Novartis

11.1.1 Novartis Company Detail

11.1.2 Novartis Business Overview

11.1.3 Novartis Injectable Targeted Therapy Introduction

11.1.4 Novartis Revenue in Injectable Targeted Therapy Business (2019-2024)

11.1.5 Novartis Recent Development

11.2 Sanofi

11.2.1 Sanofi Company Detail

11.2.2 Sanofi Business Overview

11.2.3 Sanofi Injectable Targeted Therapy Introduction

11.2.4 Sanofi Revenue in Injectable Targeted Therapy Business (2019-2024)

11.2.5 Sanofi Recent Development

11.3 GSK

11.3.1 GSK Company Detail

11.3.2 GSK Business Overview

11.3.3 GSK Injectable Targeted Therapy Introduction

11.3.4 GSK Revenue in Injectable Targeted Therapy Business (2019-2024)

11.3.5 GSK Recent Development

11.4 Bayer

11.4.1 Bayer Company Detail

11.4.2 Bayer Business Overview

11.4.3 Bayer Injectable Targeted Therapy Introduction

11.4.4 Bayer Revenue in Injectable Targeted Therapy Business (2019-2024)

11.4.5 Bayer Recent Development

11.5 Amgen

11.5.1 Amgen Company Detail

11.5.2 Amgen Business Overview

11.5.3 Amgen Injectable Targeted Therapy Introduction

11.5.4 Amgen Revenue in Injectable Targeted Therapy Business (2019-2024)

11.5.5 Amgen Recent Development

11.6 Merck

11.6.1 Merck Company Detail

11.6.2 Merck Business Overview

11.6.3 Merck Injectable Targeted Therapy Introduction

11.6.4 Merck Revenue in Injectable Targeted Therapy Business (2019-2024)

11.6.5 Merck Recent Development

11.7 AbbiVie

11.7.1 AbbiVie Company Detail

11.7.2 AbbiVie Business Overview

11.7.3 AbbiVie Injectable Targeted Therapy Introduction

11.7.4 AbbiVie Revenue in Injectable Targeted Therapy Business (2019-2024)

11.7.5 AbbiVie Recent Development

11.8 AstraZeneca

11.8.1 AstraZeneca Company Detail

11.8.2 AstraZeneca Business Overview

11.8.3 AstraZeneca Injectable Targeted Therapy Introduction

11.8.4 AstraZeneca Revenue in Injectable Targeted Therapy Business (2019-2024)

11.8.5 AstraZeneca Recent Development

11.9 Teva

11.9.1 Teva Company Detail

11.9.2 Teva Business Overview

11.9.3 Teva Injectable Targeted Therapy Introduction

11.9.4 Teva Revenue in Injectable Targeted Therapy Business (2019-2024)

11.9.5 Teva Recent Development

11.10 Roche

11.10.1 Roche Company Detail

11.10.2 Roche Business Overview

11.10.3 Roche Injectable Targeted Therapy Introduction

11.10.4 Roche Revenue in Injectable Targeted Therapy Business (2019-2024)

11.10.5 Roche Recent Development

11.11 Pfizer

11.11.1 Pfizer Company Detail

11.11.2 Pfizer Business Overview

11.11.3 Pfizer Injectable Targeted Therapy Introduction

11.11.4 Pfizer Revenue in Injectable Targeted Therapy Business (2019-2024)

11.11.5 Pfizer Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Injectable Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Monoclonal Antibodies

Table 3. Key Players of Small-Molecules

Table 4. Key Players of Immunotoxins

Table 5. Key Players of Others

Table 6. Global Injectable Targeted Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Injectable Targeted Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Injectable Targeted Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Injectable Targeted Therapy Market Share by Region (2019-2024)

Table 10. Global Injectable Targeted Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Injectable Targeted Therapy Market Share by Region (2025-2030)

Table 12. Injectable Targeted Therapy Market Trends

Table 13. Injectable Targeted Therapy Market Drivers

Table 14. Injectable Targeted Therapy Market Challenges

Table 15. Injectable Targeted Therapy Market Restraints

Table 16. Global Injectable Targeted Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Injectable Targeted Therapy Market Share by Players (2019-2024)

Table 18. Global Top Injectable Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Targeted Therapy as of 2023)

Table 19. Ranking of Global Top Injectable Targeted Therapy Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Injectable Targeted Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Injectable Targeted Therapy Product Solution and Service

Table 23. Date of Enter into Injectable Targeted Therapy Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Injectable Targeted Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Injectable Targeted Therapy Revenue Market Share by Type (2019-2024)

Table 27. Global Injectable Targeted Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Injectable Targeted Therapy Revenue Market Share by Type (2025-2030)

Table 29. Global Injectable Targeted Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Injectable Targeted Therapy Revenue Market Share by Application (2019-2024)

Table 31. Global Injectable Targeted Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Injectable Targeted Therapy Revenue Market Share by Application (2025-2030)

Table 33. North America Injectable Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Injectable Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Injectable Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Injectable Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Injectable Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Injectable Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Injectable Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Injectable Targeted Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Injectable Targeted Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Injectable Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Injectable Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Injectable Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Injectable Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Injectable Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Injectable Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 48. Novartis Company Detail

Table 49. Novartis Business Overview

Table 50. Novartis Injectable Targeted Therapy Product

Table 51. Novartis Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)

Table 52. Novartis Recent Development

Table 53. Sanofi Company Detail

Table 54. Sanofi Business Overview

Table 55. Sanofi Injectable Targeted Therapy Product

Table 56. Sanofi Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)

Table 57. Sanofi Recent Development

Table 58. GSK Company Detail

Table 59. GSK Business Overview

Table 60. GSK Injectable Targeted Therapy Product

Table 61. GSK Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)

Table 62. GSK Recent Development

Table 63. Bayer Company Detail

Table 64. Bayer Business Overview

Table 65. Bayer Injectable Targeted Therapy Product

Table 66. Bayer Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)

Table 67. Bayer Recent Development

Table 68. Amgen Company Detail

Table 69. Amgen Business Overview

Table 70. Amgen Injectable Targeted Therapy Product

Table 71. Amgen Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)

Table 72. Amgen Recent Development

Table 73. Merck Company Detail

Table 74. Merck Business Overview

Table 75. Merck Injectable Targeted Therapy Product

Table 76. Merck Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)

Table 77. Merck Recent Development

Table 78. AbbiVie Company Detail

Table 79. AbbiVie Business Overview

Table 80. AbbiVie Injectable Targeted Therapy Product

Table 81. AbbiVie Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)

Table 82. AbbiVie Recent Development

Table 83. AstraZeneca Company Detail

Table 84. AstraZeneca Business Overview

Table 85. AstraZeneca Injectable Targeted Therapy Product

Table 86. AstraZeneca Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)

Table 87. AstraZeneca Recent Development

Table 88. Teva Company Detail

Table 89. Teva Business Overview

Table 90. Teva Injectable Targeted Therapy Product

Table 91. Teva Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)

Table 92. Teva Recent Development

Table 93. Roche Company Detail

Table 94. Roche Business Overview

Table 95. Roche Injectable Targeted Therapy Product

Table 96. Roche Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)

Table 97. Roche Recent Development

Table 98. Pfizer Company Detail

Table 99. Pfizer Business Overview

Table 100. Pfizer Injectable Targeted Therapy Product

Table 101. Pfizer Revenue in Injectable Targeted Therapy Business (2019-2024) & (US$ Million)

Table 102. Pfizer Recent Development

Table 103. Research Programs/Design for This Report

Table 104. Key Data Information from Secondary Sources

Table 105. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Injectable Targeted Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Injectable Targeted Therapy Market Share by Type: 2023 VS 2030

Figure 3. Monoclonal Antibodies Features

Figure 4. Small-Molecules Features

Figure 5. Immunotoxins Features

Figure 6. Others Features

Figure 7. Global Injectable Targeted Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Injectable Targeted Therapy Market Share by Application: 2023 VS 2030

Figure 9. Hospitals Case Studies

Figure 10. Homecare Case Studies

Figure 11. Specialty Clinics Case Studies

Figure 12. Others Case Studies

Figure 13. Injectable Targeted Therapy Report Years Considered

Figure 14. Global Injectable Targeted Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Injectable Targeted Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Injectable Targeted Therapy Market Share by Region: 2023 VS 2030

Figure 17. Global Injectable Targeted Therapy Market Share by Players in 2023

Figure 18. Global Top Injectable Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Injectable Targeted Therapy as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Injectable Targeted Therapy Revenue in 2023

Figure 20. North America Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Injectable Targeted Therapy Market Share by Country (2019-2030)

Figure 22. United States Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Injectable Targeted Therapy Market Share by Country (2019-2030)

Figure 26. Germany Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Injectable Targeted Therapy Market Share by Region (2019-2030)

Figure 34. China Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Injectable Targeted Therapy Market Share by Country (2019-2030)

Figure 42. Mexico Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Injectable Targeted Therapy Market Share by Country (2019-2030)

Figure 46. Turkey Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Injectable Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Novartis Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)

Figure 49. Sanofi Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)

Figure 50. GSK Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)

Figure 51. Bayer Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)

Figure 52. Amgen Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)

Figure 53. Merck Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)

Figure 54. AbbiVie Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)

Figure 55. AstraZeneca Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)

Figure 56. Teva Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)

Figure 57. Roche Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)

Figure 58. Pfizer Revenue Growth Rate in Injectable Targeted Therapy Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

Our Clients